ArticlePloS one2026

RIPK3 inhibitor GSK872 targets angiotensin II induced cardiomyocyte hypertrophy by regulating Ca2+/ calmodulin dependent protein kinase II.

Jingjing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.